Explore more publications!

Press Releases

Health Turkiye Platform Offers New Assurance for International Patients; Dr. Resul Yaman Clinic Listed as Accredited
Genomics Market to Reach USD 115.4B by 2031 at 18.7% CAGR, Driven by Precision Medicine Adoption
Sports Hospitality Market to Grow by USD 8115.46 million from 2025-2033
Choosing a Pico Laser Solution for Tattoo and Pigment Removal Backed by FDA, Medical CE, MDSAP, MHRA and ISO
Turkey pushes for phase two of Gaza truce amid rising violence—FM

Turkey pushes for phase two of Gaza truce amid rising violence—FM

Syria’s FM phones Ahmed al-Ahmed, hero of Bondi Beach shooting

Syria’s FM phones Ahmed al-Ahmed, hero of Bondi Beach shooting

TAP Expands International Brokerage Connectivity Across Europe, the Middle East, Africa, Asia, and Latin America
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Medical Second Opinion Market to Reach US$12.7B by 2031 at 14.8% CAGR, North America Leads with 45%
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Dietary Supplements Market Size Expected to Reach USD 430.39 Bn by 2034 Driven by Preventive Healthcare, Personalized Nutrition, and Rising Health Awareness
 Faces and Revieve Establish a New Era of Beauty Innovation in the Middle East with AI-Powered Skin Advisor
 Faces and Revieve Establish a New Era of Beauty Innovation in the Middle East with AI-Powered Skin Advisor
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
Future Leading Packing Machine Exporter Targets Middle East Market at Gulf Print & Pack
Israel Unveils National Data Infrastructure to Power the Next Wave of AI-Driven Health and Agriculture Innovation
Electronic Medical Records Market to Reach US$31.55B by 2033 at 6.2% CAGR, North America Leads 42%
ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions